Five patients that responded to therapy had the best response 6?months after the final treatment with rituximab. Seven patients were enrolled. The best overall response rate according to the 1996 NCI-WG Guidelines, the primary endpoint of the study, was 71.4% (95% confidence interval, 29.0C96.3%), with one patient achieving complete response. No deaths or progression occurred […]